Description: Ventana Biotech, Inc. is a biotech company with a focus on identifying, evaluating, acquiring, developing and partnering to achieve commercialization of intellectual property in the area of drug candidates for personalized medicine. The Issuer has primarily targeted areas of anti-obesity and related illnesses.
1 Bachstrasse
Butschwil,
9606
Switzerland
Phone:
41 44 732 60 59
Officers
| Name | Title |
|---|---|
| Ms. Janne Christensen | Chief Executive Officer, President, Chief Financial Officer, Treasurer and Director |
| Mr. David Holsworth | Chief Operating Officer, Vice President and Executive Director |
| Ms. Marilyn Thom | Vice President of Administration & Human Resources |
| Mr. Elliott Martin | Vice President of Sales and Marketing |
| Mr. Trevor Conn | Executive Director |
| Mr. Yoon Youngkeun | Secretary and Director |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Financials |
|---|---|
| GIC Group: | Financial Services |
| GIC Industry: | Capital Markets |
| GIC Sub-Industry: | Asset Management & Custody Banks |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | |
| Fiscal Year End: | April |
| Full Time Employees: | 0 |